Literature DB >> 26832884

Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.

Francisco Igor B Macedo1, Joseph J Eid2, Jeff Flynn3, Michael J Jacobs2, Vijay K Mittal2.   

Abstract

BACKGROUND: Occult breast cancer (OBC) represents a rare clinical entity and poses a therapeutic dilemma. Due to limited experience, no optimal treatment approaches have yet been established.
METHODS: A meta-analysis was performed using MEDLINE and EMBASE databases to identify all studies investigating the surgical options for OBC: (1) axillary lymph node dissection (ALND) with radiotherapy (XRT); (2) ALND with mastectomy; and (3) ALND alone. Comparative studies including nonoperative management (observation or XRT alone) were excluded. The primary endpoints were locoregional recurrence, distant metastasis, and mortality rates.
RESULTS: The literature search yielded 42 publications. Seven studies met the inclusion criteria comprising 241 patients. Among these patients, 94 (39 %) underwent ALND with XRT, 112 (46.5 %) underwent mastectomy, and 35 (14.5 %) underwent ALND alone. Mean follow-up was 61.8 ± 16.2 months (range 5-396 months). Locoregional recurrence (12.7 vs. 9.8 %), distant metastasis (7.2 vs. 12.7 %), and mortality rates (9.5 vs. 17.9 %) were similar between ALND with XRT and mastectomy. ALND with XRT was superior to ALND alone regarding locoregional recurrence (12.7 vs. 34.3 %, p < 0.01) and there was a trend toward improved mortality rates (9.5 vs. 31.4 %, p = 0.09).
CONCLUSIONS: There was no difference in survival outcomes between mastectomy and ALND with XRT of patients with OBC. Radiotherapy improves locoregional recurrence and, possibly mortality rates of patients undergoing ALND. Based on this meta-analysis, combined ALND and radiation therapy may appear as the optimal surgical approach in these patients.

Entities:  

Mesh:

Year:  2016        PMID: 26832884     DOI: 10.1245/s10434-016-5104-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).

Authors:  Damian P McCartan; Emily C Zabor; Monica Morrow; Kimberly J Van Zee; Mahmoud B El-Tamer
Journal:  Ann Surg Oncol       Date:  2017-07-12       Impact factor: 5.344

Review 2.  Current Management of the Axilla.

Authors:  Damian McCARTAN; Mary L Gemignani
Journal:  Clin Obstet Gynecol       Date:  2016-12       Impact factor: 2.190

3.  Angiosarcoma arising in the non-operated, sclerosing breast after primary irradiation, surviving 6 years post-resection: A case report and review of the Japanese literature.

Authors:  Takaaki Ito; Kenichiro Tanaka; Kiyoshi Suzumura; Yoshichika Okamoto; Koji Oda; Syouji Hoshi; Masaki Terasaki
Journal:  Int J Surg Case Rep       Date:  2016-05-06

4.  Clinical and pathological portraits of axillary presentation breast cancer and effects of preoperative systemic therapy.

Authors:  Ling Xu; Fang Li; Yinhua Liu; Xuening Duan; Jingming Ye; Yuanjia Cheng; Ling Xin
Journal:  Chin J Cancer Res       Date:  2017-08       Impact factor: 5.087

5.  Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.

Authors:  Byoung Hyuck Kim; Jeanny Kwon; Kyubo Kim
Journal:  Cancer Res Treat       Date:  2017-06-01       Impact factor: 4.679

Review 6.  Occult breast cancer: Where are we at?

Authors:  Adam Ofri; Katrina Moore
Journal:  Breast       Date:  2020-10-27       Impact factor: 4.380

7.  Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy.

Authors:  Astrid Botty Van den Bruele; Jessica Lavery; George Plitas; Melissa L Pilewskie
Journal:  Ann Surg Oncol       Date:  2020-08-19       Impact factor: 5.344

8.  Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Yong-Xiong Chen; Zhen-Yu He
Journal:  J Cancer       Date:  2017-10-17       Impact factor: 4.207

9.  Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.

Authors:  Li-Ping Ge; Xi-Yu Liu; Yi Xiao; Zong-Chao Gou; Shen Zhao; Yi-Zhou Jiang; Gen-Hong Di
Journal:  Cancer Manag Res       Date:  2018-10-09       Impact factor: 3.989

10.  A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy?

Authors:  Yajing Huang; Hao Wu; Zhiyong Luo
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.